EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma

Lilong Zhang, Chen Chen, Dongqi Chai, Tianrui Kuang, Wenhong Deng, Weixing Wang

Frontiers in Microbiology · 06.01.2023 · 13

DOI: 10.3389/fmicb.2022.1090392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 06.01.2023. Verfasst von Lilong Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Intrahepatic cholangiocarcinoma (ICC) is a silent liver malignancy with an increasing incidence. Gut mycobiota plays a crucial role in benign liver diseases; however, its correlation with ICC remains elusive. This study aimed to elucidate fungal differences in patients with ICC compared to healthy controls.

Methods

The 40 fecal samples from 23 ICC patients and 17 healthy controls were collected and analyzed using ITS2 rDNA sequencing. Obtaining the OTUs and combining effective grouping, we carried out the biodiversity and composition of the fungi, as well as FUNGuild functional annotation.

Results

Our results revealed the presence of intestinal fungal dysbiosis with significant enrichment of opportunistic pathogenic fungi such as Candida and C. albicans, and significant depletion of the beneficial fungus Saccharomyces cerevisiae in ICC patients compared with healthy controls. Alpha-diversity analysis demonstrated that patients with ICC showed decreased fungal diversity compared to healthy controls. Beta diversity analysis indicated that the two groups exhibited significant segregated clustering. Besides, C. albicans was found to be significantly more abundant in the ICC patients with TNM stage III-IV than those with stage I-II. The FUNGuild functional classification predicted that pathotrophs were the most abundant taxon in the ICC group, well above their abundance in healthy controls.

Conclusion

This study indicates that dysbiosis of the fecal mycobiome might be involved in ICC development. Further research into gut fungi may contribute to new therapeutic options for ICC patients.

Schlagwörter

Stichwörter der Autor:innen

Candida albicansITS2 rDNA sequencingdysbiosisgut mycobiomeintrahepatic cholangiocarcinoma

Autor:innen und Institutionen

  • Department of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
  • Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
  • Hubei Key Laboratory of Digestive System Disease, Wuhan, Hubei, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, L., Chen, C., Chai, D., Kuang, T., Deng, W., & Wang, W. (2023). Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma. Frontiers in Microbiology, 13. https://doi.org/10.3389/fmicb.2022.1090392

Vancouver

Zhang L, Chen C, Chai D, Kuang T, Deng W, Wang W. Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma. Frontiers in Microbiology. 2023;13. doi:10.3389/fmicb.2022.1090392

BibTeX
@article{Zhang2023,
  author = {Zhang, Lilong and Chen, Chen and Chai, Dongqi and Kuang, Tianrui and Deng, Wenhong and Wang, Weixing},
  title = {Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma},
  journal = {Frontiers in Microbiology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fmicb.2022.1090392}
}
Kostenlos starten →